Inventor
JOHN D. MURRAY
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G16Bprimary
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology18%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data18%
A61BDiagnosis9%
A61FFilters implantable into blood vessels9%
B01DSeparation9%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry9%
B03CMagnetic or electrostatic separation of solid materials from solid materials or fluids9%
C07KPeptides9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
PatentTitleYear
12,544,277Protectors of reconstructed nipples in human post-mastectomy breast reconstruction202612,270,808Paramagnetic immunobeads for the isolation of human adipose-derived stem cells202512,167,846Multi-functional surgical instrument202411,842,793Methods and tools for detecting, diagnosing, predicting, prognosticating, or treating a neurobehavioral phenotype in a subject202311,791,016Methods and systems for computer-generated predictive application of neuroimaging and gene expression mapping data2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023Patents assigned to NEUMORA THERAPEUTICS INC (2)· patent assignee history
2023Patents assigned to UNIV YALE (2)· patent assignee history
2023–2026Based in US· patent location history
2024–2026Patents assigned to UNIV FLORIDA (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV FLORIDA | 3 | 2024–2026 |
| NEUMORA THERAPEUTICS INC | 2 | 2023 |
| UNIV YALE | 2 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2023–2026 |